Aktiesnakken — Juli 2010
-
solsen det er alt for lavt. 300-400 mln dollars for fabrik og zalut
-
venner genmab bliver den stærkest stigende danske aktie i 2010 og 2011
-
Da han snakkede om de tidligere nævnte $650 mio milestones hørte jeg så rigtig
der nu er $200 tilbage? -
nej
-
de 200 er på ra, så er der 200 på onc, 200 på salg
-
han sagde noget om at de var nu på 590... og ca. 1/3 del RA... 1/3 onkologi og 1/3 sales
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind